Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Idoven logo — Re-defining the way cardiovascular diseases are detected and...

Idoven

Re-defining the way cardiovascular diseases are detected and treated with Artificial Intelligence (AI)

Founded 2018 Spain Spain 63 employees Venture round Total: $22.49M AI, Health Care +2

General Information

Company Name Idoven
Founded Year 2018
Location Spain Spain
Employees 63
Industries AI, Health Care, Health and Wellness +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Idoven. To contact Idoven, visit idoven.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Idoven compare?

A PDF of Idoven and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Idoven soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Idoven

Idoven is a health technology startup based in Spain, founded in 2018. The company's mission is to redefine the way cardiovascular diseases are detected and treated using Artificial Intelligence (AI). Their AI-powered platform, certified as EU MDR Medical Device Class IIa, significantly enhances the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation. Through exclusive partnerships and research collaborations, Idoven has developed one of the world’s largest ECG databases and a deep learning system applied to cardiology. The company's software is designed to seamlessly integrate into existing clinical and research workflows, supporting clinician decision-making and disease management. Idoven has received recognition for its AI technology in Europe and the US, including the European Innovation Council (EIC) Accelerator, Horizon 2020 (H2020) awards, and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. The company has garnered support from prominent investors such as Insight Partners, Northzone, Hambro Perks, Gasol16 Ventures, Adam Chekroud, and Luis Sanz. As of 05 September 2023, Idoven secured a Venture Round investment, demonstrating continued confidence from investors in the company's innovative approach to cardiovascular care. With its strong investor support and cutting-edge technology, Idoven is poised to make a significant impact in the Health Care industry.

Business keywords: Health Technology, AI-Powered Platform, Cardiovascular Diseases, ECG Interpretation, Precision Medicine, Medical Device Integration, Disease Biomarkers, Risk Stratification, Drug Safety Monitoring, Deep Learning System, Clinical Decision Support, Innovation Distinctions, Investors, Research Collaborations

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 6
Insight Partners Northzone Hambro Perks
Insight Partners, Northzone +4
05 Sep 2023
Grant €1.50M 1
EIT Health
31 Jul 2023
Series A €12.00M 9
Insight Partners Northzone Wayra
Insight Partners, Northzone +7
21 Jun 2022
Grant €6.50M 1
European Innovation Council
European Innovation Council
21 Jun 2022
Grant €487.75K 1
European Innovation Council
European Innovation Council
21 Sep 2021
Seed Round €2.00M 5
European Innovation Council Wayra
European Innovation Council, Wayra +3
24 May 2021
Non Equity Assistance Undisclosed 1
Google for Startups
03 Feb 2020

Latest News

View All
Kylian Mbappe joins growing squad of footballers investing in European tech — Thenextweb
Kylian Mbappe joins growing squad of footballers investing in European tech
Thenextweb Oct 01, 2024

Idoven Alternatives & Competitors

View All Alternatives
Idoven vs
Powerful Medical
Powerful Medical United States

Leading the AI revolution in cardiovascular care.

Seed
54 employees
AI, Analytics
Compare Idoven vs Powerful Medical
Idoven vs
Multiomic Health
Multiomic Health United Kingdom

AI-Enabled Precision Medicine for Cardiovascular Renal Metabolic (CRM) Disease

Seed
13 employees
AI, Biotechnology
Compare Idoven vs Multiomic Health
Idoven vs
Perceiv
Perceiv Canada

Pioneering the digital infrastructure for modern neurological care.

Seed
6 employees
AI, Analytics
Also compare with: Idoven vs Nucleai Nucleai View all alternatives

FAQ About Idoven

Re-defining the way cardiovascular diseases are detected and treated with Artificial Intelligence (AI)
Idoven was founded in 2018.
Idoven is headquartered in Spain.
Idoven operates in AI, Health Care, Health and Wellness and Machine Learning. Its work centres on Health Technology, AI-Powered Platform, Cardiovascular Diseases and ECG Interpretation.
Idoven has approximately 63 employees.
Idoven has completed 7 funding rounds, raising a total of $22.49M. The latest funding stage is Venture round.
Top alternatives and competitors to Idoven include Powerful Medical, Multiomic Health, Perceiv, Aignostics, Predict4Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Idoven and Powerful Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Idoven, https://bouncewatch.com/company/idoven, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes